Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 2 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Head and Neck Neoplasms 4 Prostatic Neoplasms 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Thyroid Nodule 1 Spinal Cord Tumor of Cervical Spine 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Retinoblastoma 1 Rectal Neoplasms 1 Pelvic Neoplasms 1 Pathologic Complete Response 1 Parotid Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Pulmonary Nodules 1 Mouth Neoplasms 1 Lymphoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Disease 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Cisplatin 38 Carboplatin 28 Gemcitabine 23 Docetaxel 20 Radiotherapy 18 Etoposide 15 Paclitaxel 13 Erlotinib Hydrochloride 13 Vinorelbine 11 Drug Therapy 11 pembrolizumab 9 aumolertinib 9 apatinib 9 Pemetrexed 9 Gefitinib 9 osimertinib 7 endostar protein 7 Thoracic Surgery, Video-Assisted 7 Blood Specimen Collection 7 camrelizumab 6 anlotinib 6 Vinblastine 6 Surgical Procedures, Operative 6 sintilimab 5 Radiosurgery 5 Fluorodeoxyglucose F18 5 Cyclophosphamide 5 Bevacizumab 5 durvalumab 4 Mitomycin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lung Neoplasms × Magnetic Resonance Imaging × Clear all

NCT04275921 2021-01-05

MRI Lung

The Clatterbridge Cancer Centre NHS Foundation Trust

Phase NA Unknown

Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡